🔎 Trials Near Me

Avaleht › Hemofiilia B › Pennsylvania

Hemofiilia B kliinilised uuringud osariigis Pennsylvania

6 uuringut haiguse Hemofiilia B jaoks otsivad osalejaid osariigis Pennsylvania.

Linnad osariigis Pennsylvania

Ametlik uuringutekst (inglise keeles)

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
  • The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 2. okt 2026 · NCT05568719

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

  • Children's Hospital of Philadelphia (CHOP), Philadelphia
VärbamineFaas 1/2
Vanused 2 ja vanemad · Mehed · Uuendatud 11. sept 2026 · NCT06379789

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

  • Hemophilia Center of Western Pennsylvania (HCWP), Pittsburgh
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 27. aug 2026 · NCT06003387

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Children's Hospital of Philadelphia, Philadelphia
  • Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
  • St. Christopher's Hospital for Children, Philadelphia
  • ja veel 1
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 17. aug 2026 · NCT04398628

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

  • Penn State Milton S Hershey Medical Center Pediatrics, Hershey
  • Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–60 · Kõik sood · Uuendatud 2. juuli 2026 · NCT06349473

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  • The Feinstein Institutes for Medical Research, Philadelphia
VärbamineFaas 3
Vanused 1–74 · Mehed · Uuendatud 1. juuli 2026 · NCT05145127

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.